Androgen-Insensitive Prostatic Cancer
1 clinical trials · Condition
◉ Watch Androgen-Insensitive Prostatic Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors (NCT05551117) | MacroGenics | 2023-06-13 |
Track Androgen-Insensitive Prostatic Cancer automatically
Every clearance here is in the API, with alerts when new ones post.